This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sandoz Gmbh. Active years: 2015-2018.
Company Filing History:
Years Active: 2015-2018
Title: Thomas Stangler: Innovator in Cell Culture Technology
Introduction
Thomas Stangler is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of cell culture mediums for protein expression. With a total of 2 patents to his name, Stangler's work is paving the way for advancements in protein production.
Latest Patents
Stangler's latest patents focus on a cell culture medium and process for protein expression that incorporates a PAM inhibitor. This innovative medium is designed to enhance the expression of proteins, utilizing a PAM inhibitor or a physiological equivalent. The detailed processes outlined in his patents provide valuable insights into improving protein production efficiency.
Career Highlights
Throughout his career, Thomas Stangler has been associated with Sandoz GmbH, where he has applied his expertise in biotechnology. His work has not only contributed to the company's research initiatives but has also positioned him as a key player in the field of protein expression technologies.
Collaborations
Stangler collaborates with talented colleagues, including Corinna Sonderegger and Julia Schmutzhard. Their combined efforts in research and development have led to innovative solutions in the biotechnology sector.
Conclusion
Thomas Stangler's contributions to cell culture technology and protein expression are noteworthy. His patents reflect a commitment to advancing biotechnological methods, and his collaborations further enhance the impact of his work.